VC firm
Rimonci Capital
- Investor type
- VC
- Investing status
- Activeas of 2026-09-22Source (opens in a new tab)
- Headquarters
- 北京市, China
- Founded
- 2016
Record updated 30 September 2026
About
Ruimengxi Capital (睿盟希资本), founded in 2016, focuses on vision science with the vision of "For better vision and insight". It explores and invests in and incubates high-potential solutions in this field, at the preclinical, clinical and early development stages worldwide, while actively promoting their translation and landing in China. Ruimengxi is positioned as "vertically operated venture capital" with "consulting, connecting and leading" as its working standard, and helps portfolio companies grow through a carefully built industry ecosystem, deep understanding of the industry, rich company management experience and detailed work plans. We plan to spend ten years completing a full life-cycle architecture in vision science: the Ruimengxi Starlight Vision Science Incubator (including a patent fund), focused on laboratory research and proof of concept; the Ruimengxi Stellar Vision Science Venture Fund (USD fund), focused on supporting early-stage and product R&D improvement as well as clinical work; and the Ruimengxi Galaxy Vision Science Industry Fund (RMB fund), which promotes the translation and landing of high-potential product technologies suited to the Chinese market and uncovers local vision science innovation.
Investment approach
- Thesis
- Focus on fields that improve people's quality of life. Firm belief in hard technology innovation. Seeking long-term cooperation with positive and knowledgeable people. Continuous service throughout the life cycle is more valuable. Detail- and results-oriented. Open to cooperation externally, actively sharing internally. Value-oriented. Showcasing China's strength in global vision science innovation.Source (opens in a new tab)
- Investing status notes
- 在全球范围内探索并投资孵化该领域内高潜力的处于临床前、临床中和早期发展阶段的解决方案
Locations
- Headquarters
- 北京市, China